Thymosin β4 attenuates microcirculatory and hemodynamic destabilization in sepsis

Expert Opinion on Biological Therapy

Volumn 15, Issue , 2015, Pages 203-210

  Bongiovanni, Dario ^a,b,c   Ziegler, Tilman ^a,d   D’Almeida, Sascha ^a   Zhang, Tianqiong ^a   Ng, Judy K M ^a,c   Dietzel, Steffen ^a   Hinkel, Rabea ^a,b,c   Kupatt, Christian ^a,b,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^d MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

Pericytes; Septic shock; Severe sepsis; Thymosin 4

Indexed keywords

INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PARVOVIRUS VECTOR; THYMOSIN BETA4; THYMOSIN; THYMOSIN BETA(4);

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CELL COUNT; CELL LOSS; CONTROLLED STUDY; GENE; HEART; HEMODYNAMICS; LACZ GENE; MICROCIRCULATION; MOUSE; MUSCLE; NONHUMAN; PERICYTE; PROTEIN BLOOD LEVEL; SEPSIS; ANIMAL; C57BL MOUSE; CAPILLARY PERMEABILITY; CELL SURVIVAL; DEPENDOPARVOVIRUS; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; WOUND HEALING;

ANIMALS; CAPILLARY PERMEABILITY; CELL SURVIVAL; DEPENDOVIRUS; GENETIC THERAPY; HEK293 CELLS; HEMODYNAMICS; HUMANS; MICE; MICE, INBRED C57BL; MICROCIRCULATION; PERICYTES; SEPSIS; THYMOSIN; TRANSFECTION; WOUND HEALING;

EID: 84965089977     PISSN: 14712598     EISSN: 17447682     Source Type: Journal    
DOI: 10.1517/14712598.2015.1006193     Document Type: Article

References (25)

1. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327
2. Levy MM, Rhodes A, Phillips GS, et al. Surviving sepsis campaign: association between performance metrics and outcomes in a 7.5-Year study. Crit Care Med 2015;43(1):3-12
3. Safer D, Elzinga M, Nachmias VT. Thymosin beta 4 and Fx, an actinsequestering peptide, are indistinguishable. J Biol Chem 1991;266:4029-32
4. Malinda KM, Sidhu GS, Mani H, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol 1999;113:364-8
5. Grant DS, Kinsella JL, Kibbey MC, et al. Matrigel induces thymosin beta 4 gene in differentiating endothelial cells. J Cell Sci 1995;108(Pt 12):3685-94
6. Bock-Marquette I, Saxena A, White MD, et al. Thymosin beta4 activates integrinlinked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 2004;432:466-72
7. Sosne G, Szliter EA, Barrett R, et al. Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp Eye Res 2002;74:293-9
8. Badamchian M, Fagarasan MO, Danner RL, et al. Thymosin beta (4) reduces lethality and down-regulates inflammatory mediators in endotoxininduced septic shock. Int Immunopharmacol 2003;3:1225-33
9. Hinkel R, Trenkwalder T, Petersen B, et al. MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2. Nat Commun 2014;5:3970
10. Park BS, Lee JO. Recognition of lipopolysaccharide pattern by TLR4 complexes. Exp Mol Med 2013;45:e66
11. Taveira da Silva AM, Kaulbach HC, Chuidian FS, et al. Brief report: shock and multiple-organ dysfunction after selfadministration of Salmonella endotoxin. N Engl J Med 1993;328:1457-60
12. Doi K, Leelahavanichkul A, Yuen PS, et al. Animal models of sepsis and sepsisinduced kidney injury. J Clin Invest 2009;119:2868-78
13. Ziegler T, Horstkotte J, Schwab C, et al. Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis. J Clin Invest 2013. [Epub ahead of print]
14. Grieger JC, Choi VW, Samulski RJ. Production and characterization of adeno-associated viral vectors. Nat Protoc 2006;1:1412-28
15. Weber C, Springer TA. Neutrophil accumulation on activated, surfaceadherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor. J Clin Invest 1997;100:2085-93
16. Kupatt C, Wichels R, Horstkotte J, et al. Molecular mechanisms of plateletmediated leukocyte recruitment during myocardial reperfusion. J Leukoc Biol 2002;72:455-61
17. Schulz C, Schafer A, Stolla M, et al. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets. Circulation 2007;116:764-73
18. Hinkel R, El-Aouni C, Olson T, et al. Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection. Circulation 2008;117:2232-40
19. Rossdeutsch A, Smart N, Dube KN, et al. Essential role for thymosin beta4 in regulating vascular smooth muscle cell development and vessel wall stability. Circ Res 2012;111:e89-102
20. Witzenbichler B, Westermann D, Knueppel S, et al. Protective role of angiopoietin-1 in endotoxic shock. Circulation 2005;111:97-105
21. David S, Park JK, Meurs M, et al. Acute administration of recombinant Angiopoietin-1 ameliorates multipleorgan dysfunction syndrome and improves survival in murine sepsis. Cytokine 2011;55:251-9
22. Kupatt C, Hinkel R, Pfosser A, et al. Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adenoassociated virus resolves chronic ischemic malperfusion role of vessel maturation. J Am Coll Cardiol 2010;56:414-22
23. Merx MW, Weber C. Sepsis and the heart. Circulation 2007;116:793-802
24. Hoesel LM, Niederbichler AD, Ward PA. Complement-related molecular events in sepsis leading to heart failure. Mol Immunol 2007;44:95-102
25. Ichinose F, Buys ES, Neilan TG, et al. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 prevents myocardial dysfunction in murine models of septic shock. Circ Res 2007;100:130-9